Back to today’s briefing

Story perspectives

AI Revolutionizes Drug Discovery, Market to Hit $3.9B

2/6/2025

34 6

Summary

Story summary

Tonix Pharmaceuticals is revolutionizing drug discovery with AI, striving to accelerate the development of therapies for numerous diseases. The AI drug discovery market is set to soar to $3.9 billion by 2027. In a promising breakthrough, Recursion's REC-994 demonstrates significant lesion volume reduction in cerebral cavernous malformation, showcasing the transformative power of AI in healthcare.

1 of 1

Story summary

Tonix Pharmaceuticals is revolutionizing drug discovery with AI, striving to accelerate the development of therapies for numerous diseases. The AI drug discovery market is set to soar to $3.9 billion by 2027. In a promising breakthrough, Recursion's REC-994 demonstrates significant lesion volume reduction in cerebral cavernous malformation, showcasing the transformative power of AI in healthcare.